Literature DB >> 22859511

Is computed tomography follow-up of patients after lobectomy for non-small cell lung cancer of benefit in terms of survival?

Dharshika Srikantharajah1, Abeer Ghuman, Myura Nagendran, Mahiben Maruthappu.   

Abstract

A best evidence topic in cardiothoracic surgery was written according to a structured protocol. The question addressed was whether following up patients after lobectomy for non-small cell lung cancer (NSCLC) with computed tomography (CT) scanning is of benefit in terms of survival. Altogether, 448 papers were found using the reported search, of which five represented the best evidence to answer the clinical question and three provided supporting evidence. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. There is no general consensus in the literature. From the limited number of papers that address the effect of CT follow-up on survival following surgery for NSCLC, three showed that CT scanning may improve the survival of patients by detecting local and distant recurrences at an earlier stage when the patient is asymptomatic. One paper showed that detection by the use of low-dose CT or simultaneous chest CT plus positron emission tomography-CT led to a longer duration of survival compared with detection by clinical suspicion (2.1 ± 0.3 vs 3.6 ± 0.2 years, p = 0.002). However, two papers broadly showed that follow-up with CT does not improve survival outcomes regardless of the site of recurrence. One such study showed that there was no clinically significant difference in survival whether patients were followed up using a strict CT protocol compared with a symptom-based follow-up (median survival after recurrence: strict 7.9 months, symptom-based 6.6 months, p = 0.219). The remaining papers supported the use of CT as a screening tool for recurrence but did not comment directly on survival. Owing to the limited and contradictory evidence, there is a need for an randomized controlled trial to assess the survival outcomes of patients followed up with a CT screening protocol vs a symptom-based follow-up.

Entities:  

Mesh:

Year:  2012        PMID: 22859511      PMCID: PMC3480610          DOI: 10.1093/icvts/ivs342

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  11 in total

1.  Usefulness of low-dose spiral CT of the chest in regular follow-up of postoperative non-small cell lung cancer patients: Preliminary report.

Authors:  Chao-Hua Chiu; Ming-Sheng Chern; Mei-Han Wu; Wen-Hu Hsu; Yu-Chung Wu; Min-Hsiung Huang; Shi-Chuan Chang
Journal:  J Thorac Cardiovasc Surg       Date:  2003-06       Impact factor: 5.209

2.  CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT.

Authors:  Zaigham Saghir; Asger Dirksen; Haseem Ashraf; Karen Skjøldstrup Bach; John Brodersen; Paul Frost Clementsen; Martin Døssing; Hanne Hansen; Klaus Fuglsang Kofoed; Klaus Richter Larsen; Jann Mortensen; Jakob Fraes Rasmussen; Niels Seersholm; Birgit Guldhammer Skov; Hanne Thorsen; Philip Tønnesen; Jesper Holst Pedersen
Journal:  Thorax       Date:  2012-01-27       Impact factor: 9.139

3.  Towards evidence-based medicine in cardiothoracic surgery: best BETS.

Authors:  Joel Dunning; Brian Prendergast; Kevin Mackway-Jones
Journal:  Interact Cardiovasc Thorac Surg       Date:  2003-12

4.  Positron emission tomography-computed tomography for postoperative surveillance in non-small cell lung cancer.

Authors:  Se Hoon Choi; Young Tae Kim; Sung Kyung Kim; Keon Wook Kang; Jin Mo Goo; Chang Hyun Kang; Joo Hyun Kim
Journal:  Ann Thorac Surg       Date:  2011-10-31       Impact factor: 4.330

5.  Accuracy of surveillance computed tomography in detecting recurrent or new primary lung cancer in patients with completely resected lung cancer.

Authors:  Robert J Korst; Amanda L Kansler; Jeffrey L Port; Paul C Lee; Nasser K Altorki
Journal:  Ann Thorac Surg       Date:  2006-09       Impact factor: 4.330

6.  Follow-up in lung cancer: how often and for what purpose?

Authors:  R N Younes; J L Gross; D Deheinzelin
Journal:  Chest       Date:  1999-06       Impact factor: 9.410

7.  CT screening for lung cancer: five-year prospective experience.

Authors:  Stephen J Swensen; James R Jett; Thomas E Hartman; David E Midthun; Sumithra J Mandrekar; Shauna L Hillman; Anne-Marie Sykes; Gregory L Aughenbaugh; Aaron O Bungum; Katie L Allen
Journal:  Radiology       Date:  2005-02-04       Impact factor: 11.105

8.  Surveillance computed tomography after complete resection for non-small cell lung cancer: results and costs.

Authors:  Robert J Korst; Heather T Gold; Michael S Kent; Jeffrey L Port; Paul C Lee; Nasser K Altorki
Journal:  J Thorac Cardiovasc Surg       Date:  2005-03       Impact factor: 5.209

9.  Systematic postoperative radiologic follow-up in patients with non-small cell lung cancer for detecting second primary lung cancer in stage IA.

Authors:  Jeffrey P Lamont; James T Kakuda; David Smith; Lawrence D Wagman; Frederic W Grannis
Journal:  Arch Surg       Date:  2002-08

10.  Brain metastasis in resected lung cancer: value of intensive follow-up with computed tomography.

Authors:  K Yokoi; N Miyazawa; T Arai
Journal:  Ann Thorac Surg       Date:  1996-02       Impact factor: 4.330

View more
  10 in total

1.  eComment. Computed tomography surveillance of lung cancer survivors: the jury is still out.

Authors:  Anand Sachithanandan
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-11

2.  Clinical Impact of Frequent Surveillance Imaging in the First Year Following Chemoradiation for Locally Advanced Non-small-cell Lung Cancer.

Authors:  Quoc-Anh Ho; Nima K Harandi; Megan E Daly
Journal:  Clin Lung Cancer       Date:  2016-11-21       Impact factor: 4.785

3.  Surveillance imaging for non-small cell lung cancer: mounting evidence that less is more.

Authors:  Angel Moran; Megan E Daly
Journal:  Transl Lung Cancer Res       Date:  2019-12

Review 4.  Liquid biopsy: monitoring cancer-genetics in the blood.

Authors:  Emily Crowley; Federica Di Nicolantonio; Fotios Loupakis; Alberto Bardelli
Journal:  Nat Rev Clin Oncol       Date:  2013-07-09       Impact factor: 66.675

5.  Challenges in Predicting Recurrence After Resection of Node-Negative Non-Small Cell Lung Cancer.

Authors:  Lucas W Thornblade; Michael S Mulligan; Katherine Odem-Davis; Billanna Hwang; Rachel L Waworuntu; Erika M Wolff; Larry Kessler; Douglas E Wood; Farhood Farjah
Journal:  Ann Thorac Surg       Date:  2018-07-19       Impact factor: 4.330

Review 6.  Surveillance imaging following definitive radiotherapy for non-small cell lung cancer: What is the clinical impact?

Authors:  Brandon A Dyer; Megan E Daly
Journal:  Semin Oncol       Date:  2018-02-09       Impact factor: 4.929

7.  The prognostic value of a Methylome-based Malignancy Density Scoring System to predict recurrence risk in early-stage Lung Adenocarcinoma.

Authors:  Lu Yang; Jing Zhang; Guangjian Yang; Haiyan Xu; Jing Lin; Lin Shao; Junling Li; Changyuan Guo; Yanru Du; Lei Guo; Xin Li; Han Han-Zhang; Chenyang Wang; Shannon Chuai; Junyi Ye; Qiaolin Kang; Hao Liu; Jianming Ying; Yan Wang
Journal:  Theranostics       Date:  2020-06-18       Impact factor: 11.556

8.  Prognostic significance of postoperative longitudinal change of serum carcinoembryonic antigen level in patients with stage I lung adenocarcinoma completely resected by single-port video-assisted thoracic surgery: a retrospective study.

Authors:  Hao Chen; Yan Jiang; Keyi Jia; Kaixuan Zhang; Natsumi Matsuura; Jin Yong Jeong; Bo Su; Xiao Zhou
Journal:  Transl Lung Cancer Res       Date:  2021-10

9.  Clinical Value of Surveillance 18F-fluorodeoxyglucose PET/CT for Detecting Unsuspected Recurrence or Second Primary Cancer in Non-Small Cell Lung Cancer after Curative Therapy.

Authors:  Chae Hong Lim; Soo Bin Park; Hong Kwan Kim; Yong Soo Choi; Jhingook Kim; Yong Chan Ahn; Myung-Ju Ahn; Joon Young Choi
Journal:  Cancers (Basel)       Date:  2022-01-27       Impact factor: 6.639

10.  More Frequent Surveillance Following Lung Cancer Resection Is Not Associated With Improved Survival: A Nationally Representative Cohort Study.

Authors:  Timothy L McMurry; George J Stukenborg; Larry G Kessler; Graham A Colditz; Melisa L Wong; Amanda B Francescatti; David R Jones; Jessica R Schumacher; Caprice C Greenberg; George J Chang; David P Winchester; Daniel P McKellar; Benjamin D Kozower
Journal:  Ann Surg       Date:  2018-10       Impact factor: 12.969

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.